Lexston Life Sciences Corp. (LEXT.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -867.71 Thousand CAD | 21.74% |
| 2022 | -1.1 Million CAD | 52.21% |
| 2021 | -2.32 Million CAD | -164.83% |
| 2020 | -876.13 Thousand CAD | -13414.27% |
| 2019 | -6483.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -498.33 Thousand CAD | -102.18% |
| 2023 Q3 | -372.67 Thousand CAD | -169.71% |
| 2023 Q2 | -138.17 Thousand CAD | -22.91% |
| 2023 Q1 | -112.41 Thousand CAD | -33.64% |
| 2023 Q4 | -246.47 Thousand CAD | 33.86% |
| 2022 Q3 | -304.97 Thousand CAD | -262.54% |
| 2022 Q2 | -84.12 Thousand CAD | 70.91% |
| 2022 Q1 | -289.21 Thousand CAD | 80.88% |
| 2022 FY | -1.1 Million CAD | 52.21% |
| 2022 Q4 | -84.12 Thousand CAD | 72.42% |
| 2021 Q4 | -1.51 Million CAD | -165.06% |
| 2021 Q3 | -570.66 Thousand CAD | 13.0% |
| 2021 Q2 | -655.93 Thousand CAD | -25.91% |
| 2021 FY | -2.32 Million CAD | -164.83% |
| 2021 Q1 | -520.96 Thousand CAD | 0.0% |
| 2020 Q3 | -594.35 Thousand CAD | -3576.56% |
| 2020 Q2 | -16.16 Thousand CAD | 0.0% |
| 2020 FY | -876.13 Thousand CAD | -13414.27% |
| 2019 FY | -6483.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -6.78 Million CAD | 87.204% |
| Asep Medical Holdings Inc | -8.22 Million CAD | 89.453% |
| BetterLife Pharma Inc. | -2.88 Million CAD | 69.965% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 88.712% |
| ChitogenX Inc. | -1.55 Million CAD | 44.163% |
| Rapid Dose Therapeutics Corp. | -4.3 Million CAD | 79.851% |
| Defence Therapeutics Inc. | -13.19 Million CAD | 93.423% |
| Entheon Biomedical Corp. | -300 Thousand CAD | -189.237% |
| Gemina Laboratories Ltd. | -5.21 Million CAD | 83.367% |
| Glow Lifetech Corp. | -1.64 Million CAD | 47.271% |
| Pharmala Biotech Holdings Inc. | -779.81 Thousand CAD | -11.272% |
| Doseology Sciences Inc. | -339.84 Thousand CAD | -155.324% |
| MYND Life Sciences Inc. | -1.51 Million CAD | 42.833% |
| Nova Mentis Life Science Corp. | -1.22 Million CAD | 29.133% |
| PharmaTher Holdings Ltd. | -3.11 Million CAD | 72.147% |
| PreveCeutical Medical Inc. | -1.27 Million CAD | 31.916% |
| Telescope Innovations Corp. | -5.72 Million CAD | 84.849% |